Tuesday 6 December 2016

NEJM Review Week of November 3, 2016

Professor Brian Andrews NEJM Recommendations for Medical Students and Tutors
Week of 3rd November 2016 (#67)
University of Notre Dame Australia (Fremantle Campus)


Occasional Editorial Comment


I have just returned from the American College of Rheumatology meetings in Washington DC and am behind in my weekly NEJM reviews. Over the next two months while students are on vacation, I will attempt to be brief in my comments and highlight articles which I believe to be the most important and ones which the students may read for intellectual pleasure over this period.  I would also like to believe that each week all students and teachers review the titles of all article on line and read at least the abstracts of interest.


Must Read Articles


Perspective

BECOMING A PHYSICIAN

Tolerating Uncertainty — The Next Medical Revolution?


When we become obsessed with finding the right answer, at the risk of oversimplifying the richly iterative and evolutionary nature of clinical reasoning, the result is the very antithesis of humanistic, individualized patient-centered care.

This is a Perspective article that MUST be read by all students and teachers. It is one of the most significant articles I have read this year as it focuses on the practice medicine in the grey-zone and accepts the concept of uncertainty in the diagnosis and treatment of the patient. It helps offers a way in which medicine can be practiced in parallel with the black-white interface concept of medicine projected by the computer screen and clearly stresses the need of the personal doctor-patient relationship. It reinforces “I really don’t know what the diagnosis is,” especially when it comes from the consultant and, should we as teachers, pause when a student makes this statement.  On occasions, maybe the student is correct.


CLINICAL PROBLEM-SOLVING

Just a Cut


A 51-year-old surgeon lacerated his left ring finger near the volar distal interphalangeal joint with a fillet knife while cleaning fish after a late summer day of fishing in coastal New England seawaters. Twelve hours later, he awoke with throbbing pain in his fingertip.

This is an excellent article describing what can go wrong if you cut your finger with a knife while filleting fish and you happen to be a surgeon taking adalimumab (a TNFa inhibitor) for rheumatoid arthritis. The article involves the anatomy of the hand, infection involving tendon sheaths and the urgency and aggressiveness in treating this type of infection.



Articles Recommended for Medical Students



REVIEW ARTICLE

Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway


The PD-1 pathway plays an essential role in maintaining immunologic self-tolerance. However, cancers can subvert the role of this pathway and blind the immune system to their presence. The molecular details of the pathway are discussed.


ORIGINAL ARTICLE

BRIEF REPORT

Fulminant Myocarditis with Combination Immune Checkpoint Blockade


Fatal autoimmune myocarditis with rhabdomyolysis and refractory arrhythmias developed in two patients treated with a combination of anti–CTLA-4 and anti–PD-1 blockers. On histologic examination, a myocardial infiltrate similar to that seen in acute cardiac allograft rejection was observed.


IMAGES IN CLINICAL MEDICINE

Emphysematous Cystitis


A 72-year-old woman with poorly controlled hyperlipidemia and diabetes presented to the ED with lower abdominal pain. Examination revealed lower abdominal tenderness, and blood tests revealed leukocytosis and elevated C-reactive protein and glucose.


IMAGES IN CLINICAL MEDICINE

Ocular Flutter in the Serotonin Syndrome


A 46-year-old woman was brought to the ED because of agitation. On arrival, she had a fever, tachycardia, and ocular flutter, as well as rigidity in the legs and myoclonus in the arms. Videos are available at NEJM.org.


Important Articles Related to Mechanisms of Disease and Translational Research


None


Other Articles which should interest medical students


None


New Pharmacological Therapies


ORIGINAL ARTICLE

Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer


In patients with advanced HR-positive, HER2-negative breast cancer, the addition of the cyclin-dependent kinase inhibitor ribociclib to letrozole was associated with a significantly higher rate of progression-free survival than placebo.

This is ground-breaking therapy whereby a cyclin-dependent kinase inhibitor (ribociclid) together with letrazole has been shown to be more effective than letrazole alone in post-menopausal women with either recurrent or metastatic HR positive, HER2 negative breast cancer.



Other articles which may be of interest to certain students


None